期刊文献+

尼可地尔与冻干重组人脑利钠肽联合治疗难治性心力衰竭疗效分析 被引量:18

下载PDF
导出
摘要 难治性(也称顽固性)心衰,为心脏未损害的最严重阶段,它是指经过抗心衰治疗后,患者症状仍显著改善,甚至进一步恶化。尽管抗心衰药物目前取得了一些进展,但心衰的发病率和病死率仍居高不下,5年存活率与恶性肿瘤相近,是临床上心血管疾病中主要的死因之一。本研究在冻干重组人脑利钠肽的基础上,联合尼可地尔治疗难治性心衰,并对治疗效果及安全性进行观察分析。
出处 《中国药物与临床》 CAS 2019年第16期2834-2836,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献3

二级参考文献35

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2付尧,杨光,白小涓,贾大林,马玉龙,齐国先.重组人脑利钠肽治疗充血性心力衰竭的疗效评价[J].中国医科大学学报,2006,35(2):191-192. 被引量:35
  • 3Kawakami R,Saito Y,Kishimoto I,et al.Over expression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase 29 expression after acute myocardial infarction[J].Circulation,2004,110(21):3306-3312.
  • 4Elkayam U,Akhter MW,Singh H,et al.Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure[J].Am J Cardiol,2004,93(2):237-240.
  • 5Yancy CW,Saltzberg MT,Berkowitz RL,et al.Safety and feasibility of using serial infusions of nesiritide for heart failure in an out patientsetting(from the FUSION I trial)[J].Am J Cardiol,2004,94(5):595-601.
  • 6Witteles RM,Kao D,Christopherson D,et al.Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized,double-blind,placebo-controlled clinical trial[J].J Am Coll Cardiol,2007,50(19):1835-1840.
  • 7Arora S,Clarke K,Srinivasan V,et al.Effect of nesiritide on renal function in patients admitted for decompensated heart failure[J].QJM,2007,100(11):699-706.
  • 8Cynthuia MB,Pasqualina S,Robert M,et al.Physiological,pathological,phar-macological,biochemical and hematologica factors affecting BNP and NT-pro BNP[J].Clinical Biochemistry,2008,41(4-5):231-239.
  • 9Tanner H,Mohacsi P,Bicer GA,et al.Cytokine activation and disease progression in patients with stable moderate chronic heart failure[J].J Heart Lung Transplant,2007,26(6):622-629.
  • 10ALLEN L A, FELKER G M, MEHRA M R, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure[J]. J Card Fail, 2010, 16(3) : 230 - 238.

共引文献5438

同被引文献197

引证文献18

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部